Rectal Shedding of SARS-CoV-2 May Persist for Up to 7 Weeks
The goal of this study was to examine the time sequences of oral and fecal viral shedding in patients with coronavirus disease 2019 (COVID-19).
Respiratory
Certain Hypertension Medications May Cut Deaths From Influenza, Pneumonia
Researchers linked the use of 2 hypertension drug classes to lower mortality for those hospitalized with flu and pneumonia.
Older Age, Comorbidity Burden Contribute to COVID-19-Related Death in Veterans
Deaths related to SARS-CoV-2 infection appear to be highest in patients older than 50 years as well as in men and patients with higher comorbidity burden.
ACTIV-2 and Operation Warp Speed: An Interview With COVID-19 Investigator, Davey Smith, MD
Davey Smith, MD, provides insight into current and future research opportunities targeting SARS-CoV-2.
Systemic Complement Activation Associated With Respiratory Failure in COVID-19
Systemic complement activation is associated with respiratory failure in patients with coronavirus disease 2019.
IV, Oral Antibiotics Comparable for Treating P aeruginosa in Cystic Fibrosis
Intravenous antibiotics do not achieve greater sustained eradication of Pseudomonas aeruginosa in patients with cystic fibrosis compared with oral therapy.
Continued Antihypertensive Medication in COVID-19 Lowers Morbidity and Mortality
Researchers conducted a prospective study to analyze the relationship between continued angiotensin-converting enzyme inhibitor (ACEi) or angiotensin II receptor blocker (ARB) use in the hospital and better clinical outcomes (ICU admission, morbidity, mortality).
Severe COVID-19 Infection, Death Risk Higher in Comorbid Interstitial Lung Disease
Patients with interstitial lung disease have an increased risk of severe disease and death associated with COVID-19.
Rehabilitation Trends in Patients With COVID-19 Requiring Invasive Ventilation
In patients with COVID-19 admitted to the ICU with a high acuity of illness and a prolonged period of mechanical ventilation, the time to start rehabilitation was often delayed because of the severity of an individual’s condition.
Pulmonary Artery Thrombi Located in Opacitated Lung Segments in COVID-19
In patients hospitalized with COVID-19, thrombi in segmental pulmonary arteries are common and are located in opacitated lung segments, which may suggest local clot formation.
-
Loading...
-
Loading...
Next post in COVID19
